TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05266417: Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

Sponsor: Gateway Institute for Brain Research · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 56 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$776,000

Rescue Site Savings

+$504,400

Unlock Full NCT05266417 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05266417 Rescue Dossier →